Market Analysis and Insights: Global Renal Stent Market
Due to the COVID-19 pandemic, the global Renal Stent market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Open End Renal Stents accounting for % of the Renal Stent global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Renal Stent market size is valued at US$ million in 2021, while the US and Europe Renal Stent are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Renal Stent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Renal Stent include Angiodynamics Inc., Opti-Med, Promepla, B. Braun Melsungen AG, Blue Neem Medical Devices Pvt Ltd, Bio-enterprise, Palex Medical, Cook Medical and Ameco Medical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Renal Stent Scope and Segment
Renal Stent market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Renal Stent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Open End Renal Stents
Closed End Renal Stents
Segment by Application
Hospital
Clinics
Others
By Company
Angiodynamics Inc.
Opti-Med
Promepla
B. Braun Melsungen AG
Blue Neem Medical Devices Pvt Ltd
Bio-enterprise
Palex Medical
Cook Medical
Ameco Medical Industries
Abbott
Boston Scientific Corporation
Teleflex Incorporated
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E